Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,109 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 35,109 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 18, 2026 Filed Mar 20, 2026 21:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,800 | $2.80 | $5,040.00 |
DisclosureSEC source: 0001087294-26-000036 · wk-form4_1774041699.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,109 Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 5 | $3.91 | $19.55 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 22 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,309 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 30, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 2 | $3.94 | $7.88 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,304 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 29, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 2 | $4.01 | $8.02 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,302 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 26, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 2 | $4.21 | $8.42 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,300 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 24, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 2 | $4.26 | $8.52 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,298 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 23, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 2 | $4.13 | $8.26 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,296 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 22, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 2 | $4.32 | $8.64 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,294 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 19, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 2 | $4.19 | $8.38 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,292 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 18, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $4.19 | $12.57 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,290 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 17, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $3.65 | $10.95 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,287 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 16, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $3.27 | $9.81 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,284 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 15, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.82 | $8.46 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,281 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 12, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.50 | $7.50 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,278 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 11, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.56 | $7.68 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,275 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 10, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.60 | $7.80 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,272 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 09, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.32 | $6.96 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,269 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 08, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.40 | $7.20 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,266 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 05, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.34 | $9.36 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,263 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 04, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.27 | $9.08 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,259 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 03, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.25 | $9.00 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,255 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 02, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.24 | $8.96 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,251 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 01, 2025 Filed Jan 6, 2026 22:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.36 | $9.44 |
DisclosureSEC source: 0001087294-26-000008 · wk-form4_1767737104.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,247 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.41 | $9.64 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,243 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.17 | $8.68 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,239 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 25, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.21 | $8.84 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,235 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 24, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.10 | $8.40 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,231 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 21, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $1.96 | $7.84 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,227 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 20, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $1.99 | $7.96 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,223 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 19, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.01 | $8.04 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,219 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 18, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $1.98 | $7.92 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,215 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 17, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 4 | $2.17 | $8.68 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,211 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 14, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.15 | $6.45 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,207 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 13, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.17 | $6.51 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,204 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 12, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $1.99 | $5.97 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,201 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 11, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.06 | $6.18 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,198 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 10, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.11 | $6.33 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,195 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 07, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.19 | $6.57 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,192 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 06, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 3 | $2.27 | $6.81 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,189 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 05, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $2.53 | $15.18 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,186 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 04, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $2.82 | $16.92 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,180 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| November 03, 2025 Filed Dec 1, 2025 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $2.80 | $16.80 |
DisclosureSEC source: 0001087294-25-000029 · wk-form4_1764626936.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,174 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 12:59 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $3.39 | $20.34 |
DisclosureSEC source: 0001684087-25-000008 · wk-form4_1762174780.xml · nonDerivative · entry 23 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,168 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 12:59 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $3.29 | $19.74 |
DisclosureSEC source: 0001684087-25-000008 · wk-form4_1762174780.xml · nonDerivative · entry 22 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,162 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 29, 2025 Filed Nov 3, 2025 12:59 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $3.26 | $19.56 |
DisclosureSEC source: 0001684087-25-000008 · wk-form4_1762174780.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,156 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 28, 2025 Filed Nov 3, 2025 12:59 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $3.28 | $19.68 |
DisclosureSEC source: 0001684087-25-000008 · wk-form4_1762174780.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 27, 2025 Filed Nov 3, 2025 12:59 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $3.49 | $20.94 |
DisclosureSEC source: 0001684087-25-000008 · wk-form4_1762174780.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,144 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 24, 2025 Filed Nov 3, 2025 12:59 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $3.51 | $21.06 |
DisclosureSEC source: 0001684087-25-000008 · wk-form4_1762174780.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,138 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 23, 2025 Filed Nov 3, 2025 12:59 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $3.44 | $20.64 |
DisclosureSEC source: 0001684087-25-000008 · wk-form4_1762174780.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,132 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 22, 2025 Filed Nov 3, 2025 12:59 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $3.62 | $21.72 |
DisclosureSEC source: 0001684087-25-000008 · wk-form4_1762174780.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,126 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.